Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feinberg

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1994
Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitisM A Jacobson, B Polsky, D Causey, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus diseaseM A Jacobson, J Gallant, L H Wang, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupW G Powderly, D Finkelstein, J Feinberg, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
The New England Journal of Medicine|December 24, 1992
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021W D Hardy, J Feinberg, D M Finkelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044J R Black, J Feinberg, R L Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials GroupD J Cotton, W G Powderly, J Feinberg, et al.
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials GroupM A Fischl, S E Krown, K P O'Boyle, et al.
The Journal of Infectious Diseases|January 1, 1990
Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumoniaF R Sattler, C J Allegra, T D Verdegem, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupS A Bozzette, D M Finkelstein, S A Spector, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Antimicrobial Agents and Chemotherapy|May 1, 1994
Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitisM A Jacobson, B Polsky, D Causey, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1994
Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus diseaseM A Jacobson, J Gallant, L H Wang, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupW G Powderly, D Finkelstein, J Feinberg, et al.
The New England Journal of Medicine|April 21, 1991
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study GroupR E McKinney, M A Maha, E M Connor, et al.
The New England Journal of Medicine|December 24, 1992
A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021W D Hardy, J Feinberg, D M Finkelstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1994
Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044J R Black, J Feinberg, R L Murphy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials GroupD J Cotton, W G Powderly, J Feinberg, et al.
Journal of Acquired Immune Deficiency Syndromes|March 1, 1993
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials GroupM A Fischl, S E Krown, K P O'Boyle, et al.
The Journal of Infectious Diseases|January 1, 1990
Trimetrexate-leucovorin dosage evaluation study for treatment of Pneumocystis carinii pneumoniaF R Sattler, C J Allegra, T D Verdegem, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupS A Bozzette, D M Finkelstein, S A Spector, et al.
Pageof 20